Metagenomi (MGX) News Today $2.61 -0.16 (-5.78%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Promising Outlook for Metagenomi, Inc.: Strategic Collaborations and Technological Advancements Drive Buy RatingJanuary 17, 2025 | markets.businessinsider.comMetagenomi advances gene editing therapies into 2025January 16, 2025 | msn.comMetagenomi outlines anticipated 2025 milestonesJanuary 16, 2025 | msn.comMetagenomi Expands Leadership and Showcases InnovationsJanuary 16, 2025 | tipranks.comMetagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated MilestonesJanuary 16, 2025 | globenewswire.comMetagenomi appoints Eric Bjerkholt to board of directorsJanuary 16, 2025 | markets.businessinsider.comMetagenomi Announces New Appointment to its Board of DirectorsJanuary 15, 2025 | globenewswire.comMetagenomi, Inc.'s (NASDAQ:MGX) market cap dropped US$12m last week; individual investors who hold 33% were hit as were institutionsJanuary 15, 2025 | finance.yahoo.comGeode Capital Management LLC Has $734,000 Position in Metagenomi, Inc. (NASDAQ:MGX)Geode Capital Management LLC increased its holdings in shares of Metagenomi, Inc. (NASDAQ:MGX - Free Report) by 105.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 338,031 shares of the company's stock after acquiringJanuary 12, 2025 | marketbeat.comMetagenomi to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 8, 2025 | globenewswire.comMetagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven analysts that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the comDecember 30, 2024 | marketbeat.comShort Interest in Metagenomi, Inc. (NASDAQ:MGX) Increases By 445.1%Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 1,480,000 shares, a growth of 445.1% from the November 30th total of 271,500 shares. Currently, 7.9% of the company's stock are sold short. Based on an average daily trading volume, of 1,760,000 shares, the days-to-cover ratio is presently 0.8 days.December 26, 2024 | marketbeat.comMetagenomi’s Gene Editing Breakthroughs and FVIII Advancements Propel Buy RatingDecember 12, 2024 | markets.businessinsider.com2 ‘Monster’ Stocks to Snap Up Before 2025December 12, 2024 | msn.comUpgraded Buy Rating for Metagenomi, Inc. Driven by Promising Hemophilia A Program and Strong Financial PositionDecember 12, 2024 | markets.businessinsider.comMetagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”December 11, 2024 | globenewswire.comHC Wainwright Issues Positive Forecast for Metagenomi (NASDAQ:MGX) Stock PriceHC Wainwright lifted their price objective on shares of Metagenomi from $7.00 to $14.00 and gave the company a "buy" rating in a report on Tuesday.December 10, 2024 | marketbeat.comMetagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual MeetingDecember 9, 2024 | globenewswire.comMetagenomi, Inc. (NASDAQ:MGX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) have received an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and six have given a buy rating toDecember 5, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. - MGXNovember 25, 2024 | prnewswire.comMGX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Metagenomi, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitNovember 25, 2024 | globenewswire.comMGX DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGXNovember 25, 2024 | globenewswire.comMGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law FirmNovember 25, 2024 | prnewswire.comFINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MetagenomiNovember 25, 2024 | businesswire.comWhat is HC Wainwright's Forecast for Metagenomi Q4 Earnings?Metagenomi, Inc. (NASDAQ:MGX - Free Report) - Equities researchers at HC Wainwright raised their Q4 2024 earnings estimates for shares of Metagenomi in a report issued on Thursday, November 21st. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings per share of ($0.52November 25, 2024 | marketbeat.comMGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. ...November 24, 2024 | gurufocus.comMGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their RightsNovember 24, 2024 | businesswire.comMGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities LawsuitNovember 23, 2024 | prnewswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)November 22, 2024 | businesswire.comMGX DEADLINE MONDAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGXNovember 22, 2024 | globenewswire.comDEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024November 22, 2024 | globenewswire.comThe Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGXNovember 22, 2024 | prnewswire.comStrong Financial Position and Promising Hemophilia A Program Bolster Metagenomi’s Buy RatingNovember 21, 2024 | markets.businessinsider.comMGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud LawsuitNovember 21, 2024 | prnewswire.comShareholders that lost money on Metagenomi, Inc. (MGX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn MoreNovember 21, 2024 | globenewswire.comMGX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In MGX To Contact Him Directly To Discuss Their OptionsNovember 21, 2024 | prnewswire.comMetagenomi (NASDAQ:MGX) Receives "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $7.00 price target on shares of Metagenomi in a research report on Thursday.November 21, 2024 | marketbeat.comNovember 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGXNovember 21, 2024 | prnewswire.comShareholders of Metagenomi, Inc. Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights – MGXNovember 20, 2024 | globenewswire.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)November 19, 2024 | globenewswire.comMGX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGXNovember 19, 2024 | globenewswire.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc.(MGX) ShareholdersNovember 19, 2024 | prnewswire.comMGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud LawsuitNovember 19, 2024 | gurufocus.comMGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud LawsuitNovember 18, 2024 | prnewswire.comMETAGENOMI ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the FirmNovember 18, 2024 | globenewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MetagenomiNovember 18, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. - MGXNovember 18, 2024 | prnewswire.comMGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities LawsuitNovember 18, 2024 | prnewswire.comLevi & Korsinsky Notifies Shareholders of Metagenomi, Inc. (MGX) of a Class Action Lawsuit and an Upcoming DeadlineNovember 18, 2024 | globenewswire.comMETAGENOMI (NASDAQ: MGX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by November 25, 2024November 18, 2024 | globenewswire.com Get Metagenomi News Delivered to You Automatically Sign up to receive the latest news and ratings for MGX and its competitors with MarketBeat's FREE daily newsletter. Email Address MGX Media Mentions By Week MGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGX News Sentiment▼0.190.46▲Average Medical News Sentiment MGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGX Articles This Week▼86▲MGX Articles Average Week Get Metagenomi News Delivered to You Automatically Sign up to receive the latest news and ratings for MGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABIVAX Société Anonyme News Today Aura Biosciences News Today Revance Therapeutics News Today Allogene Therapeutics News Today Prime Medicine News Today Kodiak Sciences News Today Terns Pharmaceuticals News Today Eton Pharmaceuticals News Today Cryoport News Today REGENXBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metagenomi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MGX Stock Alerts